Rob Storey Senior Lecturer and Honorary Consultant in Cardiology, University of Sheffield, Sheffield UK Adjunctive Therapy New Agents – Will They Have A Role? My Conflicts…
Antiplatelet Options for ACS: The Changing Landscape Antiplatelet Options for ACS: The Changing Landscape Dr Harald Vangerow Medical Advisor Cardiovascular Eli Lilly UKEFF00329…
Rob Storey Reader and Honorary Consultant in Cardiology, University of Sheffield The changing world of adjunctive pharmacology * Disclosures Company Name Relationship AstraZeneca…